Discover CME, tools, and guideline-focused education to improve your knowledge - and patient outcomes.
EHA 2026: Long-Term Zanubrutinib Outcomes
Alessandra Tedeschi, MD
EHA 2026: Sonrotoclax Plus Zanubrutinib in Frontline CLL
Chan Y. Cheah, MBBS
IBD Masterclass: Choosing the Right IBD Therapy - A Patient-Clinician Connection
Florence Odufalu, MD
Ugo Iroku, MD, MHS
ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
Aditya Bardia, MD, MPH, FASCO
A Q-Challenge™ Replay: Advancing Precision Diagnosis and Treatment Strategies in Acromegaly
Maria Fleseriu, MD, FACE
Shlomo Melmed, MBChB
Elise M. Brett, MD, FACE
DESTINY-Breast05 Findings Lead to New Indication for Trastuzumab Deruxtecan as Adjuvant Treatment for Residual Invasive Disease
Sara A. Hurvitz, MD, FACP
Seeing the Invisible: Radiologic Precision to Enable Early Intervention in Bronchiectasis
Robert D. Suh, MD
Ashwin Basavaraj, MD
Mary Salvatore, MD, MBA
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
July 08, 2026
06:00 PM - 07:30 PM ET
Ongoing Trials in Oral Targeted Strategies in Breast Cancer
Rapid Data Pulses From ASCO 2026: Emerging Data on Oral Targeted Strategies in Breast Cancer
Erica L. Mayer, MD, MPH
IBD Care Reimagined: Personalized, Proactive, and Target-Driven Management
David T. Rubin, MD
Michael Dolinger, MD, MBA
Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP
Choosing the Path Forward: A Real-World Dialogue on Perioperative Immunotherapy
Adam J. Luginbuhl, MD
Turning Evidence Into Action: Applying Perioperative Data to Real-World Practice
Jennifer Johnson, MD, PhD
Making the Right Moves in Metastatic CSPC: Intensification, Imaging, and Impact
Neeraj Agarwal, MD, FASCO
Rana McKay, MD
Before the Scalpel: Identifying Candidates for Perioperative Immunotherapy
Partnering Through Treatment: Preparing for Immunotherapy in the Perioperative Setting
Talking Through Treatment: Patient–Clinician Dialogue on Perioperative Immunotherapy in Locally Advanced HNSCC
All Hands on Deck: Multidisciplinary Coordination for Smarter Perioperative Care
Putting It All Together: Challenges Addressed
Genetic Susceptibility in IBD: From Risk Genes to Clinical Impact
SERENA-6: Acting on ESR1 Mutations in Advanced Breast Cancer
TROPION-Breast02: Evidence for the Approval of Datopotamab Deruxtecan for Patients With mTNBC Ineligible for Immunotherapy
Tiffany Traina, MD, FASCO
Beyond Biology: Environmental and Lifestyle Influences in IBD
Pathophysiology of IBD: The War Within
Targeting Inflammation in IBD: Localized vs Systemic Strategies
Retina Rumble: Debating Modern Treatment Options
Roger A. Goldberg, MD, MBA
Christina Y. Weng, MD, MBA, FASRS
Yasha S. Modi, MD
Loading...
We're glad to see you're enjoying Prova Education… but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.